Cost–Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference28 articles.
1. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011
2. Validation of clinical classification schemes for predicting stroke: results from the National Registry Of Atrial Fibrillation;Gage;JAMA,2001
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation;Arch Intern Med,1994
4. Risk factors for intracranial hemorrhage in outpatients taking warfarin;Hylek;Ann Intern Med,1994
5. Risk factors for intracerebral hemorrhage in the general population: a systematic review;Ariesen;Stroke,2003
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost‐Effectiveness and Budget Impact Analysis of Apixaban and Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Non‐Valvular Atrial Fibrillation (NVAF) in Iran;Clinical Cardiology;2024-06
2. Prediction of prognosis in patients with ischemic stroke combined with type 2 diabetes mellitus based on serum total bilirubin levels;Medicine;2024-03-22
3. Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China;Journal of NeuroInterventional Surgery;2023-06-16
4. Cost effectiveness of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients in Saudi Arabia: A Single–Center retrospective cohort study;Saudi Pharmaceutical Journal;2023-01
5. Deciding the Gold Standard for Oral Anticoagulation Therapy;World Journal of Cardiovascular Diseases;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3